← Leaderboards

Zhen Jane Wang

University Of California, San Francisco

Google Scholar ↗PubMed ↗ORCID ↗

$4,501,373

Attributed

$8,657,385

Total exposure

5

Grants

2

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY2013–25

$2M$1.5M$1M$500K$0

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$8,657,385 · 5

By mechanism

R01$8,213,260 · 4

R21$444,125 · 1

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Magnetic Resonance Imaging”

Michael W Weiner · Northern California Institute Res &Educ$151,227,246
Paul S. Aisen · Cognition Therapeutics, Inc.$114,102,468
Reisa A. Sperling · Banner Health$112,709,449
Randall J Bateman · Washington University$108,056,165
Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
Joseph E Robertson · Oregon Health & Science University$93,739,249

Research focus

Magnetic Resonance ImagingResponseMetabolicBiological MarkersGlycolysisImageFutureMetabolismDiagnosisMetabolic ImagingExcisionMalignant NeoplasmsPathway InteractionsEvaluationSignal TransductionLinkMotivationKidneyCessation Of LifeInnovationMolecular ImagingMonitorOperative Surgical ProceduresImaging Techniques

Grant awards (21)

Translating Hyperpolarized 13C MRI as a Novel Tool to Predict Treatment Response in Pancreatic Cancer$670,223

R01 · FY2025 · CA

Translating Hyperpolarized 13C Metabolic MRI to Predict Renal Tumor Aggressiveness$634,908

R01 · FY2025 · CA · contact PI

Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy$1

R01 · FY2025 · CA

Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy$702,342

R01 · FY2024 · CA

Translating Hyperpolarized 13C MRI as a Novel Tool to Predict Treatment Response in Pancreatic Cancer$670,223

R01 · FY2024 · CA

Translating Hyperpolarized 13C Metabolic MRI to Predict Renal Tumor Aggressiveness$603,163

R01 · FY2024 · CA · contact PI

Translating Hyperpolarized 13C Metabolic MRI to Predict Renal Tumor Aggressiveness$622,209

R01 · FY2023 · CA · contact PI

Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy$598,284

R01 · FY2023 · CA

Translating Hyperpolarized 13C Metabolic MRI to Predict Renal Tumor Aggressiveness$74,836

R01 · FY2023 · CA · contact PI

Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy$596,548

R01 · FY2022 · CA

Translating Hyperpolarized 13C Metabolic MRI to Predict Renal Tumor Aggressiveness$590,068

R01 · FY2022 · CA · contact PI

Hyperpolarized 13C Metabolic MRI for Noninvasive Monitoring of Kidney Injury$242,250

R21 · FY2022 · DK

Translating Hyperpolarized 13C Metabolic MRI to Predict Renal Tumor Aggressiveness$40,529

R01 · FY2022 · CA · contact PI

Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy$624,558

R01 · FY2021 · CA

Translating Hyperpolarized 13C Metabolic MRI to Predict Renal Tumor Aggressiveness$599,430

R01 · FY2021 · CA · contact PI

Hyperpolarized 13C Metabolic MRI for Noninvasive Monitoring of Kidney Injury$201,875

R21 · FY2021 · DK

Hyperpolarized 13C Markers of Diabetic Nephropathy and Treatment Response$237,750

R01 · FY2017 · DK · contact PI

Hyperpolarized 13C Markers of Diabetic Nephropathy and Treatment Response$237,750

R01 · FY2016 · DK · contact PI

Hyperpolarized 13C Markers of Diabetic Nephropathy and Treatment Response$237,750

R01 · FY2015 · DK · contact PI

Hyperpolarized 13C Markers of Diabetic Nephropathy and Treatment Response$237,063

R01 · FY2014 · DK · contact PI

Hyperpolarized 13C Markers of Diabetic Nephropathy and Treatment Response$235,625

R01 · FY2013 · DK · contact PI